Literature DB >> 22100165

Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines.

Eva Gottwein1, David L Corcoran, Neelanjan Mukherjee, Rebecca L Skalsky, Markus Hafner, Jeffrey D Nusbaum, Priscilla Shamulailatpam, Cassandra L Love, Sandeep S Dave, Thomas Tuschl, Uwe Ohler, Bryan R Cullen.   

Abstract

Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100165      PMCID: PMC3222872          DOI: 10.1016/j.chom.2011.09.012

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  49 in total

1.  In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.

Authors:  Jennifer L Umbach; Bryan R Cullen
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

2.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Authors:  Daphna Nachmani; Noam Stern-Ginossar; Ronit Sarid; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

3.  Patterns of microRNA expression characterize stages of human B-cell differentiation.

Authors:  Jenny Zhang; Dereje D Jima; Cassandra Jacobs; Randy Fischer; Eva Gottwein; Grace Huang; Patricia L Lugar; Anand S Lagoo; David A Rizzieri; Daphne R Friedman; J Brice Weinberg; Peter E Lipsky; Sandeep S Dave
Journal:  Blood       Date:  2009-02-06       Impact factor: 22.113

4.  Characterization of viral and human RNAs smaller than canonical MicroRNAs.

Authors:  Zhihua Li; Sang Woo Kim; Yuefeng Lin; Patrick S Moore; Yuan Chang; Bino John
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 5.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

6.  Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs.

Authors:  Joseph M Ziegelbauer; Christopher S Sullivan; Don Ganem
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

7.  Alternative processing of primary microRNA transcripts by Drosha generates 5' end variation of mature microRNA.

Authors:  Haoquan Wu; Chunting Ye; Danielle Ramirez; N Manjunath
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

8.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.

Authors:  Shuo Gu; Lan Jin; Feijie Zhang; Peter Sarnow; Mark A Kay
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

9.  Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation.

Authors:  Priya Bellare; Don Ganem
Journal:  Cell Host Microbe       Date:  2009-12-17       Impact factor: 21.023

10.  An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival.

Authors:  Elizabeth Yee-Wai Choy; Kam-Leung Siu; Kin-Hang Kok; Raymond Wai-Ming Lung; Chi Man Tsang; Ka-Fai To; Dora Lai-Wan Kwong; Sai Wah Tsao; Dong-Yan Jin
Journal:  J Exp Med       Date:  2008-10-06       Impact factor: 14.307

View more
  181 in total

1.  EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.

Authors:  Kasandra J Riley; Gabrielle S Rabinowitz; Therese A Yario; Joseph M Luna; Robert B Darnell; Joan A Steitz
Journal:  EMBO J       Date:  2012-03-30       Impact factor: 11.598

Review 2.  Diverse virus-host interactions influence RNA-based regulation during γ-herpesvirus infection.

Authors:  Lisa M Kronstad; Britt A Glaunsinger
Journal:  Curr Opin Microbiol       Date:  2012-06-09       Impact factor: 7.934

3.  Infection of Epstein-Barr virus in a gastric carcinoma cell line induces anchorage independence and global changes in gene expression.

Authors:  Aron R Marquitz; Anuja Mathur; Kathy H Y Shair; Nancy Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-30       Impact factor: 11.205

Review 4.  The duality of oncomiR addiction in the maintenance and treatment of cancer.

Authors:  Christopher J Cheng; Frank J Slack
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 5.  EBV Noncoding RNAs.

Authors:  Rebecca L Skalsky; Bryan R Cullen
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.

Authors:  C Coarfa; W Fiskus; V K Eedunuri; K Rajapakshe; C Foley; S A Chew; S S Shah; C Geng; J Shou; J S Mohamed; B W O'Malley; N Mitsiades
Journal:  Oncogene       Date:  2015-09-14       Impact factor: 9.867

7.  Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.

Authors:  Aron R Marquitz; Anuja Mathur; Rachel Hood Edwards; Nancy Raab-Traub
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus suppression of DUSP1 facilitates cellular pathogenesis following de novo infection.

Authors:  Zhiqiang Qin; Lu Dai; Michael Defee; Victoria J Findlay; Dennis K Watson; Bryan P Toole; Jennifer Cameron; Francesca Peruzzi; Keith Kirkwood; Chris Parsons
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 9.  Multiple functions are mediated by the miRNAs of Epstein-Barr virus.

Authors:  Malika Kuzembayeva; Mitchell Hayes; Bill Sugden
Journal:  Curr Opin Virol       Date:  2014-05-10       Impact factor: 7.090

10.  Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.

Authors:  Qin Yan; Xinting Ma; Chenyou Shen; Xu Cao; Ninghan Feng; Di Qin; Yi Zeng; Jianzhong Zhu; Shou-Jiang Gao; Chun Lu
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.